أرسل هذا في رسالة قصيرة: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

             ___                _____             
  ____      / _ \\    ____     |  ___||     ___   
 |    \\   / //\ \\  |    \\   | ||__      /   || 
 | [] ||  |  ___  || | [] ||   | ||__     | [] || 
 |  __//  |_||  |_|| |  __//   |_____||    \__ || 
 |_|`-`   `-`   `-`  |_|`-`    `-----`      -|_|| 
 `-`                 `-`                     `-`